Pharmaceutical Clinical Advisors
Arkadiusz Dudek, M.D., Ph.D.
University of Minnesota
Dr. Dudek is an Associate Professor of Medicine and Director of the Clinical Trials Office in the Hematology, Oncology and Transplantation Division at the University of Minnesota. He received his M.D. from the Medical University of Warsaw, Poland. Dr. Dudek completed his internal medicine residency in Harrisburg, Pennsylvania and subspecialty training in Hematology, Oncology and Transplantation at the University of Minnesota. He received his Ph.D. from Military Medical Academy of Warsaw.
Roy S. Herbst, M.D., Ph.D.
Yale Cancer Center
Dr. Herbst is Chief of Medical Oncology and Associate Director for Translational Research at the Yale Cancer Center. He received his medical degree from Cornell University Medical College and a Ph.D. in Molecular Cell Biology from Rockefeller University. He completed his medical oncology fellowship at Dana Farber Cancer Institute and a medical hematology fellowship at Brigham and Women’s Hospital in Boston, where he additionally received a master’s degree from Harvard University in their clinical investigator training program. His research focus is on the diagnosis and treatment of lung cancers.
Jerome Ritz, M.D.
Dana-Farber Cancer Institute
Dr. Ritz is Professor of Medicine, Harvard Medical School; Professor of Medicine, Dana-Farber Cancer Institute; and Director, Cell Manipulation Core Facility, Dana-Farber Harvard Cancer Center, Boston. Dr. Ritz received his M.D. from Chicago Medical School, followed by residency in internal medicine at the University of Wisconsin Hospitals, Madison. He completed a clinical fellowship in hematology and oncology at Beth Israel Hospital, and a research fellowship at Dana-Faber Cancer Institute. Dr. Ritz also has a M.A. from Harvard University.
Leonard B. Saltz, M.D.
Memorial Sloan-Kettering Cancer Center
Dr. Saltz is a Member of Memorial Sloan-Kettering Cancer Center and Attending Physician at Memorial Hospital for Cancer and Allied Diseases, New York, NY. A Professor of Medicine at Cornell University’s Weill College of Medicine, Dr. Saltz is an internationally recognized expert in the development of new treatments for colorectal cancer. He received his doctorate from Yale University School of Medicine and completed residencies at The New York Hospital/Cornell Medical Center. Dr. Saltz completed fellowships at The New York Hospital/Cornell Medical Center, The Rockefeller University. He was instrumental in the development of Erbitux®, a monoclonal antibody from ImClone Systems.
Eric Van Cutsem, M.D., Ph.D.
University Hospital Gasthuisberg
Professor Van Cutsem is currently Professor of Internal Medicine at the University of Leuven, Belgium, and head of the division of Digestive Oncology at the University Hospital Gasthuisberg in Leuven. He obtained the degree of medical doctor at the University of Leuven, specializing in internal medicine. Professor Van Cutsem is holder of the special chair Digestive Oncology at the University of Leuven and has a mandate as senior clinical researcher of the Fund for Scientific Research.